Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.066 EUR
−43.03 M EUR
12.39 M EUR
346.98 M
About ANTENGENE CORP LTD
Sector
Industry
CEO
Jian Ming Mei
Website
Headquarters
Suzhou
Founded
2018
FIGI
BBG010JWLT55
Antengene Corp. Ltd. operates as a clinical-stage Asia-Pacific biopharmaceutical company. It focuses on the discovery, development, manufacturing and commercialization of therapeutics for the treatment of hematologic malignancies and solid tumors. It operates in mainland China, Taiwan China, Hong Kong China, Macau China, South Korea, Singapore, Malaysia, Thailand, Indonesia and Australia countries. The company was founded by Jian Ming Mei on August 28, 2018, and is headquartered in Shanghai, China.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange ANTENGENE CORP. DL-,0001 stocks are traded under the ticker 722.
We've gathered analysts' opinions on ANTENGENE CORP. DL-,0001 future price: according to them, 722 price has a max estimate of 0.72 EUR and a min estimate of 0.29 EUR. Watch 722 chart and read a more detailed ANTENGENE CORP. DL-,0001 stock forecast: see what analysts think of ANTENGENE CORP. DL-,0001 and suggest that you do with its stocks.
Yes, you can track ANTENGENE CORP. DL-,0001 financials in yearly and quarterly reports right on TradingView.
ANTENGENE CORP. DL-,0001 is going to release the next earnings report on Aug 22, 2025. Keep track of upcoming events with our Earnings Calendar.
722 earnings for the last half-year are −0.03 EUR per share, whereas the estimation was −0.04 EUR, resulting in a 7.41% surprise. The estimated earnings for the next half-year are −0.03 EUR per share. See more details about ANTENGENE CORP. DL-,0001 earnings.
ANTENGENE CORP. DL-,0001 revenue for the last half-year amounts to 4.12 M EUR, despite the estimated figure of 4.57 M EUR. In the next half-year revenue is expected to reach 7.67 M EUR.
722 net income for the last half-year is −20.53 M EUR, while the previous report showed −21.63 M EUR of net income which accounts for 5.13% change. Track more ANTENGENE CORP. DL-,0001 financial stats to get the full picture.
No, 722 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 21, 2025, the company has 169 employees. See our rating of the largest employees — is ANTENGENE CORP. DL-,0001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ANTENGENE CORP. DL-,0001 EBITDA is −45.53 M EUR, and current EBITDA margin is −367.42%. See more stats in ANTENGENE CORP. DL-,0001 financial statements.
Like other stocks, 722 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ANTENGENE CORP. DL-,0001 stock right from TradingView charts — choose your broker and connect to your account.